From: Interpretation of active-control randomised trials: the case for a new analytical perspective involving averted events
BNT162b2
Experimental vaccine
Person-years follow-up per arm
10,000
Efficacy
95%
80%
Observed COVID-19 cases
20
80
COVID-19 cases if subjects had not been vaccinated
400
Averted COVID-19 cases
380
320